Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

November 01, 1992; Volume 42,Issue 5
  • You have access
    Evidence for nucleoside diphosphokinase-dependent channeling of guanosine 5'-(gamma-thio)triphosphate to guanine nucleotide-binding proteins.
    T Wieland and K H Jakobs
    Molecular Pharmacology November 1992, 42 (5) 731-735;
  • You have access
    Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation.
    N E Kaminski, M E Abood, F K Kessler, B R Martin and A R Schatz
    Molecular Pharmacology November 1992, 42 (5) 736-742;
  • You have access
    Epidermal growth factor activates phospholipase C in rat hepatocytes via a different mechanism from that in A431 or rat1hER cells.
    M Liang and J C Garrison
    Molecular Pharmacology November 1992, 42 (5) 743-752;
  • You have access
    Coexisting beta 1- and atypical beta-adrenergic receptors cause redundant increases in cyclic AMP in human neuroblastoma cells.
    T A Esbenshade, C Han, T L Theroux, J G Granneman and K P Minneman
    Molecular Pharmacology November 1992, 42 (5) 753-759;
  • You have access
    Peptide inhibitors of ADP-ribosylation by pertussis toxin are substrates with affinities comparable to those of the trimeric GTP-binding proteins.
    R Graf, J Codina and L Birnbaumer
    Molecular Pharmacology November 1992, 42 (5) 760-764;
  • You have access
    Indirect effect of guanine nucleotides on antagonist binding to A1 adenosine receptors: occupation of cryptic binding sites by endogenous vesicular adenosine.
    M R Prater, H Taylor, R Munshi and J Linden
    Molecular Pharmacology November 1992, 42 (5) 765-772;
  • You have access
    Long term beta-adrenoceptor-mediated up-regulation of Gi alpha and G(o) alpha mRNA levels and pertussis toxin-sensitive guanine nucleotide-binding proteins in rat heart.
    T Eschenhagen, U Mende, M Diederich, M Nose, W Schmitz, H Scholz, J Schulte am Esch, A Warnholtz and H Schäfer
    Molecular Pharmacology November 1992, 42 (5) 773-783;
  • You have access
    Adenylyl cyclase and guanine nucleotide-binding proteins in supersensitive guinea pig ventricles.
    M I Roberts, P S Biser, J M Stadel, D A Taylor and W W Fleming
    Molecular Pharmacology November 1992, 42 (5) 784-791;
  • You have access
    Isolation and characterization of imidazoline receptor protein from bovine adrenal chromaffin cells.
    H Wang, S Regunathan, M P Meeley and D J Reis
    Molecular Pharmacology November 1992, 42 (5) 792-801;
  • You have access
    Consequences of 6-thioguanine incorporation into DNA on polymerase, ligase, and endonuclease reactions.
    Y H Ling, J Y Chan, K L Beattie and J A Nelson
    Molecular Pharmacology November 1992, 42 (5) 802-807;
  • You have access
    Characterization of homologous 5-hydroxytryptamine4 receptor desensitization in colliculi neurons.
    H Ansanay, M Sebben, J Bockaert and A Dumuis
    Molecular Pharmacology November 1992, 42 (5) 808-816;
  • You have access
    8-hydroxy-2-(di-n-propylamino)tetralin-responsive 5-hydroxytryptamine4-like receptor expressed in bovine pulmonary artery smooth muscle cells.
    B N Becker, T W Gettys, J P Middleton, C L Olsen, F J Albers, S L Lee, B L Fanburg and J R Raymond
    Molecular Pharmacology November 1992, 42 (5) 817-825;
  • You have access
    Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide.
    K D Burris and E Sanders-Bush
    Molecular Pharmacology November 1992, 42 (5) 826-830;
  • You have access
    Modulation of cardiac cyclic AMP metabolism by adenosine receptor agonists and antagonists.
    H Ma and R D Green
    Molecular Pharmacology November 1992, 42 (5) 831-837;
  • You have access
    Cannabinoid agonists stimulate both receptor- and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones.
    C C Felder, J S Veluz, H L Williams, E M Briley and L A Matsuda
    Molecular Pharmacology November 1992, 42 (5) 838-845;
  • You have access
    Long term treatment with desipramine increases the turnover of alpha 2-adrenoceptors in the rat brain.
    F Barturen and J A Garcia-Sevilla
    Molecular Pharmacology November 1992, 42 (5) 846-855;
  • You have access
    Prolonged D2 antidopaminergic activity of alkylating and nonalkylating derivatives of spiperone in rat brain.
    R J Baldessarini, N S Kula, A Campbell, V Bakthavachalam, J Yuan and J L Neumeyer
    Molecular Pharmacology November 1992, 42 (5) 856-863;
  • You have access
    Complex pharmacological properties of recombinant alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor subtypes.
    E Stein, J A Cox, P H Seeburg and T A Verdoorn
    Molecular Pharmacology November 1992, 42 (5) 864-871;
  • You have access
    Kinetic properties of alpha 1 beta 1 gamma-aminobutyric acidA receptor channels expressed in Chinese hamster ovary cells: regulation by pentobarbital and picrotoxin.
    N M Porter, T P Angelotti, R E Twyman and R L MacDonald
    Molecular Pharmacology November 1992, 42 (5) 872-881;
  • You have access
    Modulation of (+)-[3H]pentazocine binding to guinea pig cerebellum by divalent cations.
    A S Basile, I A Paul, A Mirchevich, G Kuijpers and B De Costa
    Molecular Pharmacology November 1992, 42 (5) 882-889;
  • You have access
    Can nicotine self-inhibition account for its low efficacy at the nicotinic acetylcholine receptor from Torpedo?
    P H Tonner, S C Wood and K W Miller
    Molecular Pharmacology November 1992, 42 (5) 890-897;
  • You have access
    Regulation of tyrosine hydroxylase gene transcription rate and tyrosine hydroxylase mRNA stability by cyclic AMP and glucocorticoid.
    L H Fossom, C R Sterling and A W Tank
    Molecular Pharmacology November 1992, 42 (5) 898-908;
  • You have access
    Depletion of 5,10-methylenetetrahydrofolate and 10-formyltetrahydrofolate by methotrexate in cultured hepatoma cells.
    M S Rhee, J K Coward and J Galivan
    Molecular Pharmacology November 1992, 42 (5) 909-916;
  • You have access
    Mechanism of inhibition of aldose reductase by menadione (vitamin K3).
    A Bhatnagar, S Q Liu, J M Petrash and S K Srivastava
    Molecular Pharmacology November 1992, 42 (5) 917-921;
  • You have access
    Nuclear magnetic resonance spectroscopy and pattern recognition analysis of the biochemical processes associated with the progression of and recovery from nephrotoxic lesions in the rat induced by mercury(II) chloride and 2-bromoethanamine.
    E Holmes, F W Bonner, B C Sweatman, J C Lindon, C R Beddell, E Rahr and J K Nicholson
    Molecular Pharmacology November 1992, 42 (5) 922-930;
  • You have access
    Metabolite intermediate complexation of microsomal cytochrome P450 2C11 in male rat liver by nortriptyline.
    M Murray
    Molecular Pharmacology November 1992, 42 (5) 931-938;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 42, Issue 5
1 Nov 1992
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Histamine H3 Receptor
  • Peptide Nanoformulations against the Tumor Microenvironment
  • Characterization of Vixotrigine
  • Dehydrocrenatidine Is a Novel JAK Inhibitor
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics